Global Parkinson’s Disease Treatment Market Insight 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The Parkinson’s Disease Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Parkinson’s Disease Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Parkinson’s Disease Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Parkinson’s Disease Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Parkinson’s Disease Treatment market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The Parkinson’s Disease Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Parkinson’s Disease Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Parkinson’s Disease Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Parkinson’s Disease Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Parkinson’s Disease Treatment market are discussed.
The market is segmented by types:
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Finally, the report provides detailed profile and data information analysis of leading company.
- Teva
- Roche
- Prothena
- Acorda Therapeutics
- Voyager Therapeutics
- Impax Pharmaceuticals
- UCB
- AbbVie
- MSD
- Orion Pharmaceuticals
- Intec Pharma
- NeuroDerm
- Adamas Therapeutics
- Acadia
- Sunovion
- GSK
- xx data tables and xx additional tables
- An overview of global Parkinson’s Disease Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Parkinson’s Disease Treatment market
- Profiles of major players in the industry, including%li% Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics.....
- To study and analyze the global Parkinson’s Disease Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Parkinson’s Disease Treatment market by identifying its various subsegments.
- Focuses on the key global Parkinson’s Disease Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the Parkinson’s Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Parkinson’s Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Parkinson’s Disease Treatment Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 Parkinson’s Disease Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 PARKINSON’S DISEASE TREATMENT INDUSTRY OVERVIEW
2.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Parkinson’s Disease Treatment Global Import Market Analysis
2.1.2 Parkinson’s Disease Treatment Global Export Market Analysis
2.1.3 Parkinson’s Disease Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Market Analysis by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.4 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Parkinson’s Disease Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Parkinson’s Disease Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Parkinson’s Disease Treatment Manufacturer Market Share
2.4.5 Top 10 Parkinson’s Disease Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Parkinson’s Disease Treatment Market
2.4.7 Key Manufacturers Parkinson’s Disease Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Parkinson’s Disease Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Parkinson’s Disease Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Parkinson’s Disease Treatment Industry
2.7.2 Parkinson’s Disease Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Parkinson’s Disease Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Parkinson’s Disease Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Regions
4.1.1 Global Parkinson’s Disease Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions (2015-2020)
4.2 Europe Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.3 APAC Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.4 North America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.5 South America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5 EUROPE PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
5.1.1 Europe Parkinson’s Disease Treatment Sales by Countries (2015-2020)
5.1.2 Europe Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
5.1.3 Germany Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.4 UK Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.5 France Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.6 Russia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.7 Italy Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.8 Spain Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.2 Europe Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
5.3.2 Europe Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
6 ASIA-PACIFIC PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Parkinson’s Disease Treatment Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
6.1.3 China Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.4 Japan Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.5 Korea Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.6 India Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.8 Australia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Parkinson’s Disease Treatment Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Parkinson’s Disease Treatment Sales and Market Share by Application (2015-2020)
7 NORTH AMERICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
7.1.1 North America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
7.1.2 North America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
7.1.3 United States Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.1.4 Canada Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.1.5 Mexico Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.2 North America Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
7.3.2 North America Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
7.4 North America Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
8 SOUTH AMERICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
8.1.2 South America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
8.1.3 Brazil Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
8.2 South America Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
8.3.2 South America Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
8.4 South America Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson’s Disease Treatment Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
9.1.3 GCC Countries Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.4 Turkey Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.5 Egypt Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.6 South Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Parkinson’s Disease Treatment Sales and Market Share by Type (2015-2020)
10.1.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Oral Sales Growth Rate and Price
10.2.1 Global Oral Sales Growth Rate (2015-2020)
10.2.2 Global Oral Price (2015-2020)
10.3 Transdermal Sales Growth Rate and Price
10.3.1 Global Transdermal Sales Growth Rate (2015-2020)
10.3.2 Global Transdermal Price (2015-2020)
10.4 Subcutaneous Sales Growth Rate and Price
10.4.1 Global Subcutaneous Sales Growth Rate (2015-2020)
10.4.2 Global Subcutaneous Price (2015-2020)
10.5 Intestinal Infusion Sales Growth Rate and Price
10.5.1 Global Intestinal Infusion Sales Growth Rate (2015-2020)
10.5.2 Global Intestinal Infusion Price (2015-2020)
11 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Parkinson’s Disease TreatmentSales Market Share by Application (2015-2020)
11.2 Hospital Pharmacy Sales Growth Rate (2015-2020)
11.3 Retail Pharmacy Sales Growth Rate (2015-2020)
11.4 Online Pharmacy Sales Growth Rate (2015-2020)
12 MARKET FORECAST FOR PARKINSON’S DISEASE TREATMENT
12.1 Global Parkinson’s Disease Treatment Revenue, Sales and Growth Rate (2020-2025)
12.2 Parkinson’s Disease Treatment Market Forecast by Regions (2020-2025)
12.2.1 Europe Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.2 APAC Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.3 North America Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.4 South America Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.5 Middle East & Africa Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.3 Parkinson’s Disease Treatment Market Forecast by Type (2020-2025)
12.3.1 Global Parkinson’s Disease Treatment Sales Forecast by Type (2020-2025)
12.3.2 Global Parkinson’s Disease Treatment Market Share Forecast by Type (2020-2025)
12.4 Parkinson’s Disease Treatment Market Forecast by Application (2020-2025)
12.4.1 Global Parkinson’s Disease Treatment Sales Forecast by Application (2020-2025)
12.4.2 Global Parkinson’s Disease Treatment Market Share Forecast by Application (2020-2025)
13 ANALYSIS OF PARKINSON’S DISEASE TREATMENT INDUSTRY KEY MANUFACTURERS
13.1 Teva
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Teva Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Teva News
13.2 Roche
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Roche Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Roche News
13.3 Prothena
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Prothena Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Prothena News
13.4 Acorda Therapeutics
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Acorda Therapeutics News
13.5 Voyager Therapeutics
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Voyager Therapeutics News
13.6 Impax Pharmaceuticals
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Impax Pharmaceuticals News
13.7 UCB
13.7.1 Company Details
13.7.2 Product Information
13.7.3 UCB Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 UCB News
13.8 AbbVie
13.8.1 Company Details
13.8.2 Product Information
13.8.3 AbbVie Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 AbbVie News
13.9 MSD
13.9.1 Company Details
13.9.2 Product Information
13.9.3 MSD Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 MSD News
13.10 Orion Pharmaceuticals
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Orion Pharmaceuticals News
13.11 Intec Pharma
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Intec Pharma Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Intec Pharma News
13.12 NeuroDerm
13.12.1 Company Details
13.12.2 Product Information
13.12.3 NeuroDerm Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 NeuroDerm News
13.13 Adamas Therapeutics
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Adamas Therapeutics News
13.14 Acadia
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Acadia Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Acadia News
13.15 Sunovion
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Sunovion Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Sunovion News
13.16 GSK
13.16.1 Company Details
13.16.2 Product Information
13.16.3 GSK Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.16.4 Main Business Overview
13.16.5 GSK News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
1 SCOPE OF THE STUDY
1.1 Parkinson’s Disease Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 PARKINSON’S DISEASE TREATMENT INDUSTRY OVERVIEW
2.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Parkinson’s Disease Treatment Global Import Market Analysis
2.1.2 Parkinson’s Disease Treatment Global Export Market Analysis
2.1.3 Parkinson’s Disease Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Market Analysis by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.4 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Parkinson’s Disease Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Parkinson’s Disease Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Parkinson’s Disease Treatment Manufacturer Market Share
2.4.5 Top 10 Parkinson’s Disease Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Parkinson’s Disease Treatment Market
2.4.7 Key Manufacturers Parkinson’s Disease Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Parkinson’s Disease Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Parkinson’s Disease Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Parkinson’s Disease Treatment Industry
2.7.2 Parkinson’s Disease Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Parkinson’s Disease Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Parkinson’s Disease Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Regions
4.1.1 Global Parkinson’s Disease Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions (2015-2020)
4.2 Europe Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.3 APAC Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.4 North America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.5 South America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5 EUROPE PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
5.1.1 Europe Parkinson’s Disease Treatment Sales by Countries (2015-2020)
5.1.2 Europe Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
5.1.3 Germany Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.4 UK Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.5 France Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.6 Russia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.7 Italy Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.1.8 Spain Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
5.2 Europe Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
5.3.2 Europe Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
6 ASIA-PACIFIC PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Parkinson’s Disease Treatment Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
6.1.3 China Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.4 Japan Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.5 Korea Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.6 India Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.1.8 Australia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Parkinson’s Disease Treatment Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Parkinson’s Disease Treatment Sales and Market Share by Application (2015-2020)
7 NORTH AMERICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
7.1.1 North America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
7.1.2 North America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
7.1.3 United States Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.1.4 Canada Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.1.5 Mexico Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
7.2 North America Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
7.3.2 North America Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
7.4 North America Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
8 SOUTH AMERICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
8.1.2 South America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
8.1.3 Brazil Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
8.2 South America Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
8.3.2 South America Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
8.4 South America Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA PARKINSON’S DISEASE TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa Parkinson’s Disease Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson’s Disease Treatment Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
9.1.3 GCC Countries Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.4 Turkey Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.5 Egypt Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.1.6 South Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Parkinson’s Disease Treatment Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Parkinson’s Disease Treatment Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Parkinson’s Disease Treatment Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Parkinson’s Disease Treatment Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Parkinson’s Disease Treatment Sales and Market Share by Type (2015-2020)
10.1.2 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Oral Sales Growth Rate and Price
10.2.1 Global Oral Sales Growth Rate (2015-2020)
10.2.2 Global Oral Price (2015-2020)
10.3 Transdermal Sales Growth Rate and Price
10.3.1 Global Transdermal Sales Growth Rate (2015-2020)
10.3.2 Global Transdermal Price (2015-2020)
10.4 Subcutaneous Sales Growth Rate and Price
10.4.1 Global Subcutaneous Sales Growth Rate (2015-2020)
10.4.2 Global Subcutaneous Price (2015-2020)
10.5 Intestinal Infusion Sales Growth Rate and Price
10.5.1 Global Intestinal Infusion Sales Growth Rate (2015-2020)
10.5.2 Global Intestinal Infusion Price (2015-2020)
11 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Parkinson’s Disease TreatmentSales Market Share by Application (2015-2020)
11.2 Hospital Pharmacy Sales Growth Rate (2015-2020)
11.3 Retail Pharmacy Sales Growth Rate (2015-2020)
11.4 Online Pharmacy Sales Growth Rate (2015-2020)
12 MARKET FORECAST FOR PARKINSON’S DISEASE TREATMENT
12.1 Global Parkinson’s Disease Treatment Revenue, Sales and Growth Rate (2020-2025)
12.2 Parkinson’s Disease Treatment Market Forecast by Regions (2020-2025)
12.2.1 Europe Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.2 APAC Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.3 North America Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.4 South America Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.2.5 Middle East & Africa Parkinson’s Disease Treatment Market Forecast (2020-2025)
12.3 Parkinson’s Disease Treatment Market Forecast by Type (2020-2025)
12.3.1 Global Parkinson’s Disease Treatment Sales Forecast by Type (2020-2025)
12.3.2 Global Parkinson’s Disease Treatment Market Share Forecast by Type (2020-2025)
12.4 Parkinson’s Disease Treatment Market Forecast by Application (2020-2025)
12.4.1 Global Parkinson’s Disease Treatment Sales Forecast by Application (2020-2025)
12.4.2 Global Parkinson’s Disease Treatment Market Share Forecast by Application (2020-2025)
13 ANALYSIS OF PARKINSON’S DISEASE TREATMENT INDUSTRY KEY MANUFACTURERS
13.1 Teva
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Teva Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Teva News
13.2 Roche
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Roche Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Roche News
13.3 Prothena
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Prothena Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Prothena News
13.4 Acorda Therapeutics
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Acorda Therapeutics News
13.5 Voyager Therapeutics
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Voyager Therapeutics News
13.6 Impax Pharmaceuticals
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Impax Pharmaceuticals News
13.7 UCB
13.7.1 Company Details
13.7.2 Product Information
13.7.3 UCB Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 UCB News
13.8 AbbVie
13.8.1 Company Details
13.8.2 Product Information
13.8.3 AbbVie Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 AbbVie News
13.9 MSD
13.9.1 Company Details
13.9.2 Product Information
13.9.3 MSD Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 MSD News
13.10 Orion Pharmaceuticals
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Orion Pharmaceuticals News
13.11 Intec Pharma
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Intec Pharma Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Intec Pharma News
13.12 NeuroDerm
13.12.1 Company Details
13.12.2 Product Information
13.12.3 NeuroDerm Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 NeuroDerm News
13.13 Adamas Therapeutics
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Adamas Therapeutics News
13.14 Acadia
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Acadia Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Acadia News
13.15 Sunovion
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Sunovion Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Sunovion News
13.16 GSK
13.16.1 Company Details
13.16.2 Product Information
13.16.3 GSK Parkinson’s Disease Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.16.4 Main Business Overview
13.16.5 GSK News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
LIST OF TABLES AND FIGURES
Figure Parkinson’s Disease Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Parkinson’s Disease Treatment Market by Regions (2019)
Table Global Market Parkinson’s Disease Treatment Comparison by Regions (M USD) 2019-2025
Table Global Parkinson’s Disease Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Parkinson’s Disease Treatment by Type in 2019
Figure Oral Picture
Figure Transdermal Picture
Figure Subcutaneous Picture
Figure Intestinal Infusion Picture
Table Global Parkinson’s Disease Treatment Sales by Application (2019-2025)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Application in 2019
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Parkinson’s Disease Treatment Sales by Manufacturer (2018-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Manufacturer in 2019
Table Global Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Global Parkinson’s Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Parkinson’s Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Parkinson’s Disease Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Parkinson’s Disease Treatment Market
Table Key Manufacturers Parkinson’s Disease Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson’s Disease Treatment
Table Key Players of Upstream Markets
Table Sales Channel
Figure Sales Channel
Figure Direct Channel Pros & Cons
Table Parkinson’s Disease Treatment Distributors List
Table Parkinson’s Disease Treatment Customers List
Figure Global Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Regions (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Regions in 2019
Table Global Parkinson’s Disease Treatment Revenue by Regions (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions in 2019
Figure Europe Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure APAC Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure North America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure South America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Middle East & Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Europe Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure Germany Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure UK Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure France Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Russia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Italy Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Spain Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Europe Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure China Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Japan Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Korea Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure India Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Australia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure North America Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table North America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure United States Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Canada Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Mexico Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table North America Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure South America Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table South America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure Brazil Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table South America Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure GCC Countries Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Egypt Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Turkey Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure South Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Global Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Type in 2019
Table Global Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Global Parkinson’s Disease Treatment Revenue Market Share by Type (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Type in 2019
Figure Global Oral Sales Growth Rate (2015-2020)
Figure Global Oral Price (2015-2020)
Figure Global Transdermal Sales Growth Rate (2015-2020)
Figure Global Transdermal Price (2015-2020)
Figure Global Subcutaneous Sales Growth Rate (2015-2020)
Figure Global Subcutaneous Price (2015-2020)
Figure Global Intestinal Infusion Sales Growth Rate (2015-2020)
Figure Global Intestinal Infusion Price (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Global Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Application in 2019
Figure Global Hospital Pharmacy Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacy Sales Growth Rate (2015-2020)
Figure Global Online Pharmacy Sales Growth Rate (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales and Growth Rate (2020-2025)
Figure Global Parkinson’s Disease Treatment Revenue and Growth Rate (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Regions (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Regions (2020-2025
Figure Europe Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure APAC Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure North America Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure South America Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure Middle East & Africa Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Type (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Type (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Application (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Application (2020-2025)
Table Teva Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Teva
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Parkinson’s Disease Treatment Market Share (2018-2020)
Table Teva Main Business
Table Teva Recent Development
Table Roche Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Roche
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Parkinson’s Disease Treatment Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Prothena Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Prothena
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Prothena Parkinson’s Disease Treatment Market Share (2018-2020)
Table Prothena Main Business
Table Prothena Recent Development
Table Acorda Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Acorda Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Acorda Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Acorda Therapeutics Main Business
Table Acorda Therapeutics Recent Development
Table Voyager Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Voyager Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Voyager Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Voyager Therapeutics Main Business
Table Voyager Therapeutics Recent Development
Table Impax Pharmaceuticals Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Impax Pharmaceuticals
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Impax Pharmaceuticals Parkinson’s Disease Treatment Market Share (2018-2020)
Table Impax Pharmaceuticals Main Business
Table Impax Pharmaceuticals Recent Development
Table UCB Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of UCB
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure UCB Parkinson’s Disease Treatment Market Share (2018-2020)
Table UCB Main Business
Table UCB Recent Development
Table AbbVie Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of AbbVie
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure AbbVie Parkinson’s Disease Treatment Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table MSD Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of MSD
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure MSD Parkinson’s Disease Treatment Market Share (2018-2020)
Table MSD Main Business
Table MSD Recent Development
Table Orion Pharmaceuticals Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Orion Pharmaceuticals
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Orion Pharmaceuticals Parkinson’s Disease Treatment Market Share (2018-2020)
Table Orion Pharmaceuticals Main Business
Table Orion Pharmaceuticals Recent Development
Table Intec Pharma Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Intec Pharma
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Intec Pharma Parkinson’s Disease Treatment Market Share (2018-2020)
Table Intec Pharma Main Business
Table Intec Pharma Recent Development
Table NeuroDerm Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of NeuroDerm
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure NeuroDerm Parkinson’s Disease Treatment Market Share (2018-2020)
Table NeuroDerm Main Business
Table NeuroDerm Recent Development
Table Adamas Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Adamas Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Adamas Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Adamas Therapeutics Main Business
Table Adamas Therapeutics Recent Development
Table Acadia Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Acadia
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Acadia Parkinson’s Disease Treatment Market Share (2018-2020)
Table Acadia Main Business
Table Acadia Recent Development
Table Sunovion Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Sunovion
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sunovion Parkinson’s Disease Treatment Market Share (2018-2020)
Table Sunovion Main Business
Table Sunovion Recent Development
Table GSK Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of GSK
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure GSK Parkinson’s Disease Treatment Market Share (2018-2020)
Table GSK Main Business
Table GSK Recent Development
Table of Appendix
Figure Parkinson’s Disease Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Parkinson’s Disease Treatment Market by Regions (2019)
Table Global Market Parkinson’s Disease Treatment Comparison by Regions (M USD) 2019-2025
Table Global Parkinson’s Disease Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Parkinson’s Disease Treatment by Type in 2019
Figure Oral Picture
Figure Transdermal Picture
Figure Subcutaneous Picture
Figure Intestinal Infusion Picture
Table Global Parkinson’s Disease Treatment Sales by Application (2019-2025)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Application in 2019
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Parkinson’s Disease Treatment Sales by Manufacturer (2018-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Manufacturer in 2019
Table Global Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Global Parkinson’s Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Parkinson’s Disease Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Parkinson’s Disease Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Parkinson’s Disease Treatment Market
Table Key Manufacturers Parkinson’s Disease Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson’s Disease Treatment
Table Key Players of Upstream Markets
Table Sales Channel
Figure Sales Channel
Figure Direct Channel Pros & Cons
Table Parkinson’s Disease Treatment Distributors List
Table Parkinson’s Disease Treatment Customers List
Figure Global Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Regions (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Regions in 2019
Table Global Parkinson’s Disease Treatment Revenue by Regions (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions in 2019
Figure Europe Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure APAC Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure North America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure South America Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Middle East & Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Europe Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure Germany Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure UK Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure France Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Russia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Italy Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Spain Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Europe Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Europe Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure China Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Japan Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Korea Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure India Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Australia Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Asia-Pacific Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure North America Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table North America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure United States Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Canada Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Mexico Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table North America Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table North America Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table North America Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure South America Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table South America Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure Brazil Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table South America Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table South America Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table South America Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Sales Market Share by Countries in 2019
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries in 2019
Figure GCC Countries Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Egypt Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure Turkey Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Figure South Africa Parkinson’s Disease Treatment Sales and Growth Rate (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Manufacturer (2018-2020)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Manufacturer in 2019
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Share by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Share by Type (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Middle East and Africa Parkinson’s Disease Treatment Sales Share by Application (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Type (2015-2020)
Table Global Parkinson’s Disease Treatment Sales Market Share by Type (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Type in 2019
Table Global Parkinson’s Disease Treatment Revenue by Type (2015-2020)
Table Global Parkinson’s Disease Treatment Revenue Market Share by Type (2015-2020)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Type in 2019
Figure Global Oral Sales Growth Rate (2015-2020)
Figure Global Oral Price (2015-2020)
Figure Global Transdermal Sales Growth Rate (2015-2020)
Figure Global Transdermal Price (2015-2020)
Figure Global Subcutaneous Sales Growth Rate (2015-2020)
Figure Global Subcutaneous Price (2015-2020)
Figure Global Intestinal Infusion Sales Growth Rate (2015-2020)
Figure Global Intestinal Infusion Price (2015-2020)
Table Global Parkinson’s Disease Treatment Sales by Application (2015-2020)
Table Global Parkinson’s Disease Treatment Sales Market Share by Application (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales Market Share by Application in 2019
Figure Global Hospital Pharmacy Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacy Sales Growth Rate (2015-2020)
Figure Global Online Pharmacy Sales Growth Rate (2015-2020)
Figure Global Parkinson’s Disease Treatment Sales and Growth Rate (2020-2025)
Figure Global Parkinson’s Disease Treatment Revenue and Growth Rate (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Regions (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Regions (2020-2025
Figure Europe Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure APAC Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure North America Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure South America Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Figure Middle East & Africa Sales Parkinson’s Disease Treatment Market Forecast (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Type (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Type (2020-2025)
Table Global Parkinson’s Disease Treatment Sales Forecast by Application (2020-2025)
Table Global Parkinson’s Disease Treatment Market Share Forecast by Application (2020-2025)
Table Teva Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Teva
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Parkinson’s Disease Treatment Market Share (2018-2020)
Table Teva Main Business
Table Teva Recent Development
Table Roche Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Roche
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Parkinson’s Disease Treatment Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Prothena Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Prothena
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Prothena Parkinson’s Disease Treatment Market Share (2018-2020)
Table Prothena Main Business
Table Prothena Recent Development
Table Acorda Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Acorda Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Acorda Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Acorda Therapeutics Main Business
Table Acorda Therapeutics Recent Development
Table Voyager Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Voyager Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Voyager Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Voyager Therapeutics Main Business
Table Voyager Therapeutics Recent Development
Table Impax Pharmaceuticals Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Impax Pharmaceuticals
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Impax Pharmaceuticals Parkinson’s Disease Treatment Market Share (2018-2020)
Table Impax Pharmaceuticals Main Business
Table Impax Pharmaceuticals Recent Development
Table UCB Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of UCB
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure UCB Parkinson’s Disease Treatment Market Share (2018-2020)
Table UCB Main Business
Table UCB Recent Development
Table AbbVie Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of AbbVie
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure AbbVie Parkinson’s Disease Treatment Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table MSD Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of MSD
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure MSD Parkinson’s Disease Treatment Market Share (2018-2020)
Table MSD Main Business
Table MSD Recent Development
Table Orion Pharmaceuticals Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Orion Pharmaceuticals
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Orion Pharmaceuticals Parkinson’s Disease Treatment Market Share (2018-2020)
Table Orion Pharmaceuticals Main Business
Table Orion Pharmaceuticals Recent Development
Table Intec Pharma Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Intec Pharma
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Intec Pharma Parkinson’s Disease Treatment Market Share (2018-2020)
Table Intec Pharma Main Business
Table Intec Pharma Recent Development
Table NeuroDerm Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of NeuroDerm
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure NeuroDerm Parkinson’s Disease Treatment Market Share (2018-2020)
Table NeuroDerm Main Business
Table NeuroDerm Recent Development
Table Adamas Therapeutics Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Adamas Therapeutics
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Adamas Therapeutics Parkinson’s Disease Treatment Market Share (2018-2020)
Table Adamas Therapeutics Main Business
Table Adamas Therapeutics Recent Development
Table Acadia Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Acadia
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Acadia Parkinson’s Disease Treatment Market Share (2018-2020)
Table Acadia Main Business
Table Acadia Recent Development
Table Sunovion Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of Sunovion
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sunovion Parkinson’s Disease Treatment Market Share (2018-2020)
Table Sunovion Main Business
Table Sunovion Recent Development
Table GSK Company Profile
Figure Parkinson’s Disease Treatment Product Picture and Specifications of GSK
Table Parkinson’s Disease Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure GSK Parkinson’s Disease Treatment Market Share (2018-2020)
Table GSK Main Business
Table GSK Recent Development
Table of Appendix
